GPX4 and ovarian carcinoma: CYLD did not influence the expression levels of RIP3 (necrosis marker), p62 and ATG5 (autophagy marker), as well as levels of GPX4 and SLC7A11 (ferroptosis marker) in ovarian cancer A2780 and OVCAR3 cell lines (Fig. S2E).